Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma

Cancer

Volumn 83, Issue 11, 1998, Pages 2270-2283

  Chua, Daniel T T ^a   Sham, Jonathan S T ^a   Choy, Damon ^a   Lorvidhaya, Virchan ^b   Sumitsawan, Yupa ^b   Thongprasert, Sumitra ^b   Vootiprux, Visoot ^c   Cheirsilpa, Arkom ^d   Azhar, Tahir ^e   Reksodiputro, Ary H ^f   Sangruchi, Supatra ^c   Roezin, Averdi ^f   Widjanarko, Abidin ^f   Susworo, ^f  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d NATIONAL CANCER INSTITUTE   (Thailand)

^e HOSPITAL KUALA LUMPUR   (Malaysia)

^f CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

Author keywords

Cisplatin; Distant metastasis; Epirubicin; Nasopharyngeal carcinoma; Neoadjuvant chemotherapy; Overall survival; Radiotherapy; Recurrence; Relapse free survival

Indexed keywords

CISPLATIN; EPIRUBICIN;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIA; CISPLATIN; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PACIFIC ISLANDS; PROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 15444347863     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981201)83:11<2270::AID-CNCR6>3.0.CO;2-T     Document Type: Article

References (37)

1. Sham JST, Cheung YK, Choy D, Chan FL, Leong L. Computed tomography evaluation of neck node metastases from nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 26:787-92.
2. Sham JST, Choy D, Wei WI. Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys 1990; 19:929-33.
3. Lee AWM, Poon YF, Foo W, Law SCK, Cheung FK, Chan DKK, et al. Retrospective analysis of 5037 patients with nasophryngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-70.
4. Tang SGJ, Lin FJ, Chen MS, Liaw CC, Leung WM, Hong JH. Prognostic factors of nasopharyngeal carcinoma: a multivariate analysis. Int J Radiat Oncol Biol Phys 1990;19:1143-9.
5. Teo P, Shiu W, Leung SF, Lee WY. Prognostic factors in nasopharyngeal carcinoma investigated by computed tomography: an anlysis of 659 patients. Radiother Oncol 1992; 23:79-93.
6. Kwong D, Sham J, Choy D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an anlysis of 1301 patients. Int J Radiat Oncol Biol Phys 1994;30:1029-36.
7. Huang SC. Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys 1980;6:401-7.
8. Lee AWM, Law SCK, Foo W, Poon YF, Chan DKK, O SK, et al. Nasopharyngeal carcinoma: local control by meganoltage irradiation. Br J Radial 1993;66:528-36.
9. Qin D, Hu Y, Yan J, Xu G, Cai W, Wu X, et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer 1988;61:1117-24.
10. Sham JST, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radial 1990;63: 51-8.
11. Azli N, Armand JP, Rahal M, Wibault P, Boussen H, Eschwege F, et al. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type. Eur J Cancer 1992;28A:1792-7.
12. Bachouchi M, Cvitkovic E, Azli N, Gasmi J, Cortes-Funes H, Boussen H, et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy. J Natl Cancer Inst 1990;82: 616-20.
13. Chi KH, Chan WK, Cooper DL, Yen SH, Lin CZ, Chen KY. A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma. Cancer 1994;73:247-52.
14. Clark JR, Fallen BG, Chaffey JT, Norris CM, Balogh K, Anderson J, et al. Nasopharyngeal carcinoma: the Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy. Ann Otol Rhinol Laryngol 1987;96:608-13.
15. Dimery IW, Peters LJ, Goepfert H, Morrisone WH, Byers RM, Guillory C, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993;11:1919-28.
16. Fountzilas G, Daniilidis J, Kosmidis P, Sridhar KS, Kalogera-Fountzilas A, Sombolos K, et al. Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer: a retrospective analysis of 39 cases. Acta Oncol 1991;30:831-4.
17. Hill BT, Price LA, MacRay K. The promising role of safe initial non-containing combination chemotherapy in nasopharyngeal carcinoma [Abstract C502]. Proc Am Soc Clin Oncol 1985;4:129.
18. Lin JC, Jan JS, Hsu CY. Neoadjuvant chemotherapy for advanced nasopharyngeal carcinoma. Am J Clin Oncol 1995; 18:139-43.
19. Boussen H, Cvitkovic E, Wendling JL, Bachouchi M, Mahjoubi R, Kalifa C, et al. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin and fluorouracil. J Clin Oncol 1991;9: 1675-81.
20. Choo R, Tannock I. Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx: a review of the Princess Margaret Hospital experience. Cancer 1991;68:2120-4.
21. Fandi A, Altun M, Armand JP, Cvitkovic E. Nasopharyngeal cancer: epidemiology, staging and treatment. Semin Oncol 1994;21:382-97.
22. Decker DA, Drelichman A, Al-Sarraf M, Crissman J, Meluin LR. Chemotherapy for nasopharyngeal carcinoma: a ten year experience. Cancer 1983;52:602-5.
23. Dugan M, Choy D, Ngai A, Sham J, Choi P, Shiu W, et al. Multicenter phase Il trial of mitoxantrone in patients with nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group study. J Clin Oncol 1993;11:70-6.
24. Huang SC, Lui LT, Lynn TC. Nasopharyngeal cancer: Study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 1985;11:1789-93.
25. Rahima M, Rakowsky E, Barzilay J, Sidi J. Carcinoma of the nasopharynx: an analysis of 91 cases and a comparison of different treatment approaches. Cancer 1986;58:843-9.
26. Shiu WCT, Tsao SY. Efficacy of 4′-epidoxorubicin (Farmorubicin) in advanced nasopharyngeal carcinoma. Clin Trials J 1988;26:149-52.
27. Teo P, Ho JH, Choy D, Choi P, Tsui KH. Adjunctive chemotherapy to radical radiation therapy in the treatment of advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1987;13:679-85.
28. Rossi A, Molinari R, Boracchi P, Vecchio MD, Marubini E, Nava M, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988;6:1401-10.
29. Chan ATC, Teo PML, Leung TWT, Leung SF, Lee WY, Yeo W, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995;33: 569-77.
30. Kuo WR, Lee KW, Ching FY, Jan YS, Juan KH. The effect of adjuvant chemotherapy for nasopharyngeal carcinoma: a preliminary report. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1993;9:9-17.
31. Rahal M, Djemaa A, Filali K, Boudaoud K. Preliminary report of high dose epirubicin and cisplatin induction chemotherapy in locally advanced bulky undifferentiated carcinoma of nasopharyngeal type [Abstract P593]. Ann Oncol 1994; 5(Suppl 8);159.
32. Oliveira J, Martins A, Lage P, Gil N, Magalhaes M, Araujo F, et al. Cisplatin and high-dose epirubicin in non-queratinizing epidermoid carcinoma of the nasopharynx [Abstract 880]. Proc Am Soc Clin Oncol 1996;15:313.
33. Ho JHC. The natural history and treatment of nasopharyngeal carcinoma. In: Clark RL, Cumley RW, McCay JE, Copeland MM, editors. Oncology. Volume 4. Chicago: Yearbook Medical Publishers, 1982:1-14.
34. American Joint Committee on Cancer. Beahrs OH, Henson DE, Hutter RVP, Myers MH, editors. Manual for staging of cancer. 3rd edition. Philadelphia: J. B. Lippincott, 1988.
35. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
36. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996; 35:463-9.
37. Gin PGS, LeBlanc M, Al-Sarraf M, Fu KK, Cooper J, Vuong T, et al. Improved survival with chemotherapy and radiation therapy versus radiation therapy alone in advanced nasopharyngeal cancer: preliminary results of an Intergroup randomized trial. INT 0099, SWOG 8892, RTOG 8817, ECOG 2388. [Abstract 8.] Int J Radiat Oncol Biol Phys 1996; 36(Suppl):162.